As it turns out the PCSK9 inhibitor saga ends not with a bang but a whimper. The results of the highly anticipated FOURIER trial show that the drugs work, though not as powerfully as many had hoped and expected. The question now will be whether the modest efficacy of the drugs is worth their immodest ...
FOURIER shows new cholesterol drugs work, but are they worth it?
By Larry Husten
20 Mar 2017